In this issue:
- Paclitaxel-coated devices: US FDA removes red flag after review finds data do not support mortality risk
- “A hugely exciting time”: Experts focus in on artificial intelligence in the vascular field
- In profile: Jürgen Falkensammer (Vienna, Austria)
- Journal highlight: Computer model indicates optimal shielding can reduce operator radiation doses close to “background” levels
- Advertorial: Mazin Foteh (Plano, USA) contrasts the benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy Catheter alongside those of its sister device, the Shockwave M5+ Peripheral Intravascular Lithotripsy Catheter
